See All Slides - tctmd.com

Slides

Presentation TCT 2015

What Have We Learned From All-Comers Head-to-Head DES Trials I? The SORT OUT Trial

Presenter: Stephen G. Ellis, John A. Ormiston, Evald H. Christiansen

October 11, 2015

Presentation TCT 2015

Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World

Presenter: Gary M. Ansel, Michael R. Jaff

October 11, 2015

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Presentation TCT 2015

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Presenter: Stuart J. Pocock, Jan Tijssen, John L. Petersen

October 11, 2015

Presentation TCT 2015

Prospective Identification of NonFlow Limiting Vulnerable Plaques and Vulnerable Patients: Data From Grayscale and RF-IVUS, OCT, and NIRS for Predicting Future Events

Presenter: Fernando Alfonso, Akiko Maehara, David Erlinge

October 11, 2015

Presentation TCT 2015

Nerve Distribution Along the Renal Arteries: From the Branches to the Ostium

Presenter: Juan F. Granada, Michael Joner

October 11, 2015

Presentation TCT 2015

Transeptal Puncture for Mitral Valve Interventions: Indications and Techniques

Presenter: Mohamed Chettibi, Ziyad M. Hijazi

October 11, 2015

Presentation TCT 2015

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Presenter: David R. Holmes Jr., Vivek Y. Reddy, Saibal Kar

October 11, 2015

Presentation TCT 2015

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? The Mechanism and Data Support Cangrelor!

Presenter: C. Michael Gibson, Marco Valgimigli, Harvey D. White

October 11, 2015

Presentation TCT 2015

The Retrograde Approach: J-CTO Registry Insights

Presenter: J. Aaron Grantham, Masahiko Ochiai, Etsuo Tsuchikane

October 11, 2015

Advertisement

Slides

What Have We Learned From All-Comers Head-to-Head DES Trials I? The SORT OUT Trial

Evolving Endovascular Treatment Strategies for Femoral-Popliteal Disease in a DES and DCB World

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Observational vs Randomized Trials: Strengths and Weaknesses (With Case Examples)

Prospective Identification of NonFlow Limiting Vulnerable Plaques and Vulnerable Patients: Data From Grayscale and RF-IVUS, OCT, and NIRS for Predicting Future Events

Nerve Distribution Along the Renal Arteries: From the Branches to the Ostium

Transeptal Puncture for Mitral Valve Interventions: Indications and Techniques

Guidelines, Recommendations, and Reimbursement for LAA Closure: A Global Survey

Debate 1: Should Cangrelor or an Oral ADP Antagonist Be Used in Most STEMI Patients? The Mechanism and Data Support Cangrelor!

The Retrograde Approach: J-CTO Registry Insights

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content